$EOLS
Evolus, Inc. Stock $eols

$eols Overview Financials Valuation SEC Filings Company Website

2019 Q4 Form 10-Q Financial Statement

#000157056219000143 Filed on November 04, 2019

Income Statement

Concept	2019 Q4	2019 Q3	2018 Q3
Revenue	$19.45M	$13.17M	$0.00
YoY Change
Cost Of Revenue	$3.640M	$3.718M	$0.00
YoY Change
Gross Profit	$15.81M	$9.449M	$0.00
YoY Change
Gross Profit Margin	81.29%	71.76%
Selling, General & Admin	$30.29M	$30.90M	$7.209M
YoY Change	147.87%	328.59%	526.87%
% of Gross Profit	191.59%	326.99%
Research & Development	$420.0K	$693.0K	$1.977M
YoY Change	-64.41%	-64.95%	34.95%
% of Gross Profit	2.66%	7.33%
Depreciation & Amortization	$1.470M	$1.202M	$3.000K
YoY Change		39966.67%
% of Gross Profit	9.3%	12.72%
Operating Expenses	$32.17M	$34.59M	$11.49M
YoY Change	139.9%	201.04%	339.18%
Operating Profit	-$16.36M	-$25.14M	-$11.49M
YoY Change		118.8%	339.18%
Interest Expense	-$2.090M	-$2.000M	-$320.0K
YoY Change	-2422.22%	525.0%
% of Operating Profit
Other Income/Expense, Net		-$2.455M	-$322.0K
YoY Change		662.42%	16000.0%
Pretax Income	-$14.64M	-$27.13M	-$11.81M
YoY Change	17.87%	129.73%	351.15%
Income Tax	-$130.0K	-$149.0K	$19.00K
% Of Pretax Income
Net Earnings	-$14.51M	-$26.98M	-$11.83M
YoY Change	16.64%	128.1%	355.0%
Net Earnings / Revenue	-74.6%	-204.94%
Basic Earnings Per Share
Diluted Earnings Per Share	-$472.0K	-$982.2K	-$477.6K
COMMON SHARES
Basic Shares Outstanding	27.43M shares	27.42M shares	26.67M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2019 Q4	2019 Q3	2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$129.8M	$74.03M	$105.2M
YoY Change	39.33%	-29.63%
Cash & Equivalents	$109.9M	$39.12M	$105.2M
Short-Term Investments	$19.91M	$34.91M
Other Short-Term Assets	$5.300M	$3.900M	$900.0K
YoY Change	341.67%	333.33%	200.0%
Inventory	$6.407M	$10.04M
Prepaid Expenses
Receivables	$10.66M	$7.206M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$152.2M	$95.18M	$106.1M
YoY Change	61.33%	-10.28%	35264.0%
LONG-TERM ASSETS
Property, Plant & Equipment	$902.0K	$984.0K	$1.000K
YoY Change		98300.0%
Goodwill	$21.21M	$21.21M	$21.21M
YoY Change	0.0%	0.0%
Intangibles	$59.64M	$59.86M	$56.08M
YoY Change	6.35%	6.74%
Long-Term Investments
YoY Change
Other Assets	$2.429M	$1.195M	$0.00
YoY Change	999.1%		-100.0%
Total Long-Term Assets	$88.25M	$87.48M	$77.29M
YoY Change	13.86%	13.19%	-48.72%
TOTAL ASSETS
Total Short-Term Assets	$152.2M	$95.18M	$106.1M
Total Long-Term Assets	$88.25M	$87.48M	$77.29M
Total Assets	$240.4M	$182.7M	$183.4M
YoY Change	39.92%	-0.39%	21.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.796M	$6.125M	$661.0K
YoY Change	272.02%	826.63%	120.33%
Accrued Expenses	$13.96M	$14.38M	$4.799M
YoY Change	275.47%	199.6%	499.88%
Deferred Revenue	$1.709M
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Long-Term Debt Due			$0.00
YoY Change
Total Short-Term Liabilities	$24.44M	$25.97M	$5.460M
YoY Change	363.21%	375.71%	-92.54%
LONG-TERM LIABILITIES
Long-Term Debt	$73.51M	$73.18M	$16.80M
YoY Change		335.6%	-87.55%
Other Long-Term Liabilities	$45.10M	$48.60M	$51.10M
YoY Change	-10.16%	-4.89%
Total Long-Term Liabilities	$73.51M	$73.18M	$67.90M
YoY Change		7.78%	-49.67%
TOTAL LIABILITIES
Total Short-Term Liabilities	$24.44M	$25.97M	$5.460M
Total Long-Term Liabilities	$73.51M	$73.18M	$67.90M
Total Liabilities	$161.0M	$165.6M	$88.41M
YoY Change	84.07%	87.33%	-61.48%
SHAREHOLDERS EQUITY
Retained Earnings	-$213.1M	-$198.6M	-$110.6M
YoY Change	73.18%	79.55%
Common Stock	$1.000K	$1.000K	$1.000K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$79.46M	$17.04M	$94.97M
YoY Change
Total Liabilities & Shareholders Equity	$240.4M	$182.7M	$183.4M
YoY Change	39.92%	-0.39%	21.44%

Cashflow Statement

Concept	2019 Q4	2019 Q3	2018 Q3
OPERATING ACTIVITIES
Net Income	-$14.51M	-$26.98M	-$11.83M
YoY Change	16.64%	128.1%	355.0%
Depreciation, Depletion And Amortization	$1.470M	$1.202M	$3.000K
YoY Change		39966.67%
Cash From Operating Activities	-$15.92M	-$25.10M	-$5.800M
YoY Change	32.56%	332.76%	69.1%
INVESTING ACTIVITIES
Capital Expenditures	-$1.140M	-$640.0K	$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$15.11M	$35.03M
YoY Change
Cash From Investing Activities	$13.98M	$34.39M	$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$67.68M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	72.73M	-460.0K	67.38M
YoY Change		-100.68%	1864.43%
NET CHANGE
Cash From Operating Activities	-15.92M	-25.10M	-5.800M
Cash From Investing Activities	13.98M	34.39M	0.000
Cash From Financing Activities	72.73M	-460.0K	67.38M
Net Change In Cash	70.79M	8.830M	61.58M
YoY Change	-689.43%	-85.66%	-3306051076096000000.0%
FREE CASH FLOW
Cash From Operating Activities	-$15.92M	-$25.10M	-$5.800M
Capital Expenditures	-$1.140M	-$640.0K	$0.00
Free Cash Flow	-$14.78M	-$24.46M	-$5.800M
YoY Change	23.06%	321.72%	69.1%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	eols	Allocated Share Based Compensation Expense Capitalized AllocatedShareBasedCompensationExpenseCapitalized	76000	USD
	eols	Amortization Of Discount On Shortterm Investments AmortizationOfDiscountOnShorttermInvestments	0	USD
	eols	Amortization Of Discount On Shortterm Investments AmortizationOfDiscountOnShorttermInvestments	-912000	USD
	eols	Capital Contribution Convertible Note Write Off CapitalContributionConvertibleNoteWriteOff	0	USD
	eols	Operating Lease Rightof Use Asset Amortization OperatingLeaseRightofUseAssetAmortization	0	USD
	eols	Operating Lease Rightof Use Asset Amortization OperatingLeaseRightofUseAssetAmortization	702000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
	dei	Document Period End Date DocumentPeriodEndDate	2019-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001570562
CY2019Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	27425230	shares
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	EVOLUS, INC.
	dei	Entity Shell Company EntityShellCompany	false
	dei	Entity Small Business EntitySmallBusiness	true
	eols	Accounts Payable Paidby Parent AccountsPayablePaidbyParent	163000	USD
	eols	Accounts Payable Paidby Parent AccountsPayablePaidbyParent	0	USD
CY2018Q4	eols	Accrued Coupon And Rebate Liability Current AccruedCouponAndRebateLiabilityCurrent	0	USD
	eols	Payments For Provisions For Accrued Volume Based Rebate And Coupon Liability PaymentsForProvisionsForAccruedVolumeBasedRebateAndCouponLiability	2739000	USD
	eols	Payments Of Contingent Royalty Obligation PaymentsOfContingentRoyaltyObligation	0	USD
	eols	Payments Of Contingent Royalty Obligation PaymentsOfContingentRoyaltyObligation	9282000	USD
	eols	Proceeds From Payments For Issuance Of Common Stock In Connection With Equity Incentive Plan ProceedsFromPaymentsForIssuanceOfCommonStockInConnectionWithEquityIncentivePlan	-239000	USD
	eols	Proceeds From Payments For Issuance Of Common Stock In Connection With Equity Incentive Plan ProceedsFromPaymentsForIssuanceOfCommonStockInConnectionWithEquityIncentivePlan	1109000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	736000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	0	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	7206000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	3825000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2000000	USD
	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	-8000	USD
	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	0	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	0	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6225000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1406000	USD
	us-gaap	Interest Paid Net InterestPaidNet	0	USD
	us-gaap	Interest Paid Net InterestPaidNet	3365000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	0	USD
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	5565000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	705000	USD
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	5000000	USD
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	0	USD
CY2019Q3	eols	Accrued Coupon And Rebate Liability Current AccruedCouponAndRebateLiabilityCurrent	3932000	USD
	eols	Capital Contribution Convertible Note Write Off CapitalContributionConvertibleNoteWriteOff	66998000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3555000	USD
CY2019Q3	eols	Allocated Share Based Compensation Expense Capitalized AllocatedShareBasedCompensationExpenseCapitalized	30000	USD
CY2018Q1	eols	Deemed Contribution From Parent Increase Of Related Party Receivable DeemedContributionFromParentIncreaseOfRelatedPartyReceivable	1051000	USD
	eols	Capital Contribution Forgivenessof Related Party Borrowings CapitalContributionForgivenessofRelatedPartyBorrowings	13188000	USD
	eols	Capital Contribution Forgivenessof Related Party Borrowings CapitalContributionForgivenessofRelatedPartyBorrowings	0	USD
CY2018Q1	eols	Capital Contribution From Parent Forgiveness Of Related Party Borrowings CapitalContributionFromParentForgivenessOfRelatedPartyBorrowings	13188000	USD
CY2018Q4	eols	Common Stock Additional Capital Shares Reservedfor Future Issuance CommonStockAdditionalCapitalSharesReservedforFutureIssuance	1091000	shares
	eols	Contingent Promissory Note ContingentPromissoryNote	16042000	USD
	eols	Contingent Promissory Note ContingentPromissoryNote	0	USD
	eols	Contingent Royalty Obligation ContingentRoyaltyObligation	39700000	USD
	eols	Contingent Royalty Obligation ContingentRoyaltyObligation	0	USD
CY2018Q4	eols	Contingent Royalty Obligation Payableto Related Party Current ContingentRoyaltyObligationPayabletoRelatedPartyCurrent	0	USD
CY2019Q3	eols	Contingent Royalty Obligation Payableto Related Party Current ContingentRoyaltyObligationPayabletoRelatedPartyCurrent	4323000	USD
CY2018Q3	eols	Fair Value Measurementwith Unobservable Inputs Reconciliation Recurring Basis Liability Payments FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityPayments	0	USD
	eols	Fair Value Measurementwith Unobservable Inputs Reconciliation Recurring Basis Liability Payments FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityPayments	0	USD
CY2019Q3	eols	Fair Value Measurementwith Unobservable Inputs Reconciliation Recurring Basis Liability Payments FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityPayments	69000	USD
	eols	Fair Value Measurementwith Unobservable Inputs Reconciliation Recurring Basis Liability Payments FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityPayments	9282000	USD
	eols	Increasedecrease In Operating Lease Liabilities IncreasedecreaseInOperatingLeaseLiabilities	0	USD
	eols	Increasedecrease In Operating Lease Liabilities IncreasedecreaseInOperatingLeaseLiabilities	-531000	USD
CY2019Q3	eols	Intangible Assets Gross Including Goodwill IntangibleAssetsGrossIncludingGoodwill	83587000	USD
	eols	Lessee Operating Lease Period Of Written Notice Prior To Lease Terminate Date LesseeOperatingLeasePeriodOfWrittenNoticePriorToLeaseTerminateDate	P12M
	eols	Lessee Operating Lease Termination Fee Period Of Rent Equivalent LesseeOperatingLeaseTerminationFeePeriodOfRentEquivalent	P6M
	eols	Lessee Operating Lease Termination Period LesseeOperatingLeaseTerminationPeriod	P36M
CY2019Q3	eols	Longterm Debt Maturities Final Payments LongtermDebtMaturitiesFinalPayments	4125000	USD
CY2019Q3	eols	Longterm Debt Maturities Final Payments In Year Five LongtermDebtMaturitiesFinalPaymentsInYearFive	4125000	USD
CY2019Q3	eols	Longterm Debt Maturities Final Payments In Year Four LongtermDebtMaturitiesFinalPaymentsInYearFour	0	USD
CY2019Q3	eols	Longterm Debt Maturities Final Payments In Year Three LongtermDebtMaturitiesFinalPaymentsInYearThree	0	USD
CY2019Q3	eols	Longterm Debt Maturities Principal Payment Excluding Final Payment LongtermDebtMaturitiesPrincipalPaymentExcludingFinalPayment	75000000	USD
CY2019Q3	eols	Longterm Debt Maturities Principal Payment Excluding Final Payment Due In Year Five LongtermDebtMaturitiesPrincipalPaymentExcludingFinalPaymentDueInYearFive	9783000	USD
CY2019Q3	eols	Longterm Debt Maturities Principal Payment Excluding Final Payment Due In Year Four LongtermDebtMaturitiesPrincipalPaymentExcludingFinalPaymentDueInYearFour	39130000	USD
CY2019Q3	eols	Longterm Debt Maturities Principal Payment Excluding Final Payment Due In Year Three LongtermDebtMaturitiesPrincipalPaymentExcludingFinalPaymentDueInYearThree	26087000	USD
CY2018Q3	eols	Milestone Payment Current MilestonePaymentCurrent	0	USD
CY2018Q4	eols	Milestone Payment Current MilestonePaymentCurrent	0	USD
CY2019Q3	eols	Milestone Payment Current MilestonePaymentCurrent	1000000	USD
	eols	Milestone Payments For Intangible Assets MilestonePaymentsForIntangibleAssets	0	USD
	eols	Milestone Payments For Intangible Assets MilestonePaymentsForIntangibleAssets	2000000	USD
	eols	Non Cash Deferred Offering Costs NonCashDeferredOfferingCosts	2885000	USD
	eols	Non Cash Deferred Offering Costs NonCashDeferredOfferingCosts	0	USD
	eols	Non Cash Finance And Insurance Payment NonCashFinanceAndInsurancePayment	0	USD
	eols	Non Cash Finance And Insurance Payment NonCashFinanceAndInsurancePayment	1561000	USD
	eols	Non Cash Landlord Paid Tenant Improvement NonCashLandlordPaidTenantImprovement	0	USD
	eols	Non Cash Landlord Paid Tenant Improvement NonCashLandlordPaidTenantImprovement	781000	USD
	eols	Non Cash Note Obligation NonCashNoteObligation	140688000	USD
	eols	Non Cash Note Obligation NonCashNoteObligation	0	USD
	eols	Non Cash Related Party Borrowings NonCashRelatedPartyBorrowings	68767000	USD
	eols	Non Cash Related Party Borrowings NonCashRelatedPartyBorrowings	0	USD
	eols	Non Cash Related Party Receivable NonCashRelatedPartyReceivable	73690000	USD
	eols	Non Cash Related Party Receivable NonCashRelatedPartyReceivable	0	USD
	eols	Operating Lease Percentage Of Annual Rent Escalation OperatingLeasePercentageOfAnnualRentEscalation	0.03
CY2019Q3	eols	Payments For Provisions For Accrued Volume Based Rebate And Coupon Liability PaymentsForProvisionsForAccruedVolumeBasedRebateAndCouponLiability	2739000	USD
CY2019Q3	eols	Provisions For Accrued Volume Based Rebate And Coupon Liability ProvisionsForAccruedVolumeBasedRebateAndCouponLiability	5740000	USD
	eols	Provisions For Accrued Volume Based Rebate And Coupon Liability ProvisionsForAccruedVolumeBasedRebateAndCouponLiability	6671000	USD
	eols	Provisions For Rebate And Coupon Programs ProvisionsForRebateAndCouponPrograms	0	USD
	eols	Provisions For Rebate And Coupon Programs ProvisionsForRebateAndCouponPrograms	6671000	USD
CY2018Q3	eols	Revaluationof Contingent Royalty Obligation Payable RevaluationofContingentRoyaltyObligationPayable	2300000	USD
	eols	Revaluationof Contingent Royalty Obligation Payable RevaluationofContingentRoyaltyObligationPayable	11400000	USD
CY2019Q3	eols	Revaluationof Contingent Royalty Obligation Payable RevaluationofContingentRoyaltyObligationPayable	1795000	USD
	eols	Revaluationof Contingent Royalty Obligation Payable RevaluationofContingentRoyaltyObligationPayable	7977000	USD
CY2018Q2	eols	Stock Issued During Period Value Issuance Of Common Stock In Connection With Incentive Equity Plan StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithIncentiveEquityPlan	-238000	USD
CY2019Q1	eols	Stock Issued During Period Value Issuance Of Common Stock In Connection With Incentive Equity Plan StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithIncentiveEquityPlan	-58000	USD
CY2019Q2	eols	Stock Issued During Period Value Issuance Of Common Stock In Connection With Incentive Equity Plan StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithIncentiveEquityPlan	853000	USD
CY2019Q3	eols	Stock Issued During Period Value Issuance Of Common Stock In Connection With Incentive Equity Plan StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithIncentiveEquityPlan	314000	USD
CY2018Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3718000	USD
CY2019Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	14378000	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1558000	USD
CY2019Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	6125000	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	0	USD
CY2019Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7206000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3718000	USD
CY2019Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	14378000	USD
CY2018Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	931000	USD
CY2019Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	4488000	USD
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	USD
CY2019Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	19000	USD
CY2018Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	207408000	USD
CY2019Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	215574000	USD
CY2018Q1	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	66998000	USD
CY2018Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1006000	USD
CY2018Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2623000	USD
CY2018Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1482000	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2015000	USD
CY2019Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2486000	USD
CY2019Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2556000	USD
CY2018Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1482000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5111000	USD
CY2019Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2526000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6981000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	749000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1513000	USD
CY2019Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1115000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2522000	USD
CY2018Q4	us-gaap	Assets Assets	171844000	USD
CY2019Q3	us-gaap	Assets Assets	182666000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	94339000	USD
CY2019Q3	us-gaap	Assets Current AssetsCurrent	95184000	USD
CY2018Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	0	USD
CY2019Q3	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	34913000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	11400000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	7977000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	147000	USD
CY2019Q3	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	761000	USD
	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	3303000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	93162000	USD
CY2019Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	39116000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	74029000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	USD
CY2018Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	105168000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	93162000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	39116000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	105168000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-54046000	USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	971684	shares
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2019Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2019Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	27274991	shares
CY2019Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	27425230	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	27274991	shares
CY2019Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	27425230	shares
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	1000	USD
CY2019Q3	us-gaap	Common Stock Value CommonStockValue	1000	USD
CY2018Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-11830000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-34425000	USD
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9000	USD
CY2019Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-27008000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-75507000	USD
CY2018Q4	us-gaap	Contractual Obligation ContractualObligation	50200000	USD
CY2019Q3	us-gaap	Contractual Obligation ContractualObligation	44572000	USD
CY2018Q1	us-gaap	Contractual Obligation ContractualObligation	39700000	USD
CY2018Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	0	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	0	USD
CY2019Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3718000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4378000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	41000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-14899000	USD
CY2018Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	15055000	USD
CY2019Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	156000	USD
CY2018Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	25000	USD
CY2019Q3	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	0	USD
CY2019Q1	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	0	USD
CY2018Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7000	USD
CY2019Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1202000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2664000	USD
CY2018Q1	us-gaap	Dividends Dividends	2002000	USD
CY2018Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.48
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.47
CY2019Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.98
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.76
CY2018Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2577000	USD
CY2019Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3453000	USD
CY2017Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	39700000	USD
CY2018Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	48800000	USD
CY2018Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	51100000	USD
CY2018Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	50200000	USD
CY2019Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	47169000	USD
CY2019Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	48895000	USD
CY2019Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2522000	USD
CY2019Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	44577000	USD
CY2019Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	1168000	USD
CY2019Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	2955000	USD
CY2019Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	2955000	USD
CY2019Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	3528000	USD
CY2019Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	4674000	USD
CY2019Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	62379000	USD
CY2019Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	59857000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	21208000	USD
CY2019Q3	us-gaap	Goodwill Goodwill	21208000	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2018Q3	us-gaap	Gross Profit GrossProfit	0	USD
	us-gaap	Gross Profit GrossProfit	0	USD
CY2019Q3	us-gaap	Gross Profit GrossProfit	9449000	USD
	us-gaap	Gross Profit GrossProfit	11100000	USD
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	USD
CY2018Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11811000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-34384000	USD
CY2019Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-27133000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-90425000	USD
CY2018Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	19000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	41000	USD
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-149000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-14899000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	378000	USD
CY2018Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	56076000	USD
CY2019Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	59857000	USD
CY2018Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	77284000	USD
CY2019Q3	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	81065000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	739000	USD
CY2019Q3	us-gaap	Lease Cost LeaseCost	352000	USD
	us-gaap	Lease Cost LeaseCost	963000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	0	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	6699000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	1484000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1312000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1258000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1205000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1201000	USD
CY2018Q3	us-gaap	Investment Income Net InvestmentIncomeNet	0	USD
	us-gaap	Investment Income Net InvestmentIncomeNet	0	USD
CY2019Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4067000	USD
CY2018Q4	us-gaap	Liabilities Liabilities	87460000	USD
CY2019Q3	us-gaap	Inventory Net InventoryNet	10043000	USD
	us-gaap	Investment Income Net InvestmentIncomeNet	1464000	USD
CY2019Q3	us-gaap	Investment Income Net InvestmentIncomeNet	460000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	239000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1484000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P60M
CY2019Q3	us-gaap	Liabilities Liabilities	165623000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	171844000	USD
CY2019Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	182666000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5276000	USD
CY2019Q3	us-gaap	Liabilities Current LiabilitiesCurrent	25974000	USD
CY2019Q3	us-gaap	Long Term Debt LongTermDebt	79125000	USD
CY2019Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	13908000	USD
CY2019Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	39130000	USD
CY2019Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	26087000	USD
CY2018Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	USD
CY2019Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	73180000	USD
CY2018Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	16904000	USD
CY2019Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	17674000	USD
CY2018Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	16042000	USD
CY2018Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	0	USD
CY2019Q3	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	118838000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	60823000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-9000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-37408000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13661000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-77461000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-6162000	USD
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	-16433000	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	-11830000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-34425000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-10975000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-37567000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-26984000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-75526000	USD
	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	unit
CY2018Q3	us-gaap	Operating Expenses OperatingExpenses	11489000	USD
	us-gaap	Operating Expenses OperatingExpenses	33634000	USD
CY2019Q3	us-gaap	Operating Expenses OperatingExpenses	34587000	USD
	us-gaap	Operating Expenses OperatingExpenses	97504000	USD
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-11489000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-33634000	USD
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-25138000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-86404000	USD
CY2019Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	297000	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	798000	USD
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	80000	USD
CY2019Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	5215000	USD
CY2018Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0	USD
CY2019Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1148000	USD
CY2018Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	USD
CY2019Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	916000	USD
CY2019Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	138000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	0	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	716000	USD
CY2018Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	USD
CY2019Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4238000	USD
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1029000	USD
CY2019Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.094
CY2019Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y88D
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	1029000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	0	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	139000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	890000	USD
CY2018Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	210000	USD
CY2019Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1505000	USD
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	221000	USD
CY2019Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1195000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	52000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-24000	USD
CY2018Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	USD
CY2019Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-24000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	19000	USD
CY2018Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-322000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-750000	USD
CY2019Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2455000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5485000	USD
	us-gaap	Payments For Software PaymentsForSoftware	0	USD
	us-gaap	Payments For Software PaymentsForSoftware	3080000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	2205000	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1060000	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	98982000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	346000	USD
CY2018Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2019Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2018Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2019Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2018Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1177000	USD
CY2019Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3906000	USD
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	67680000	USD
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	56330000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	0	USD
CY2019Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	984000	USD
CY2019Q3	us-gaap	Purchase Obligation PurchaseObligation	6651000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	65000000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	73906000	USD
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	1127000	USD
CY2018Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7209000	USD
CY2018Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1977000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5303000	USD
CY2019Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	693000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-123025000	USD
CY2019Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-198551000	USD
CY2018Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	0	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	0	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13167000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15478000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	16924000	USD
CY2019Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	30897000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	83308000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	5111000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	6981000	USD
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	4361291	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum	0.04
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P10Y
CY2019Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	24000	USD
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	73000	USD
CY2018Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	67380000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	-75543000	USD
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	51982000	USD
CY2018Q2	us-gaap	Stockholders Equity StockholdersEquity	37934000	USD
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	94966000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	84384000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	75357000	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	41181000	USD
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	17043000	USD
CY2019Q1	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-14402000	USD
CY2018	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	34500000	USD
CY2019Q3	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-149000	USD
	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-497000	USD
CY2019Q3	us-gaap	Variable Lease Cost VariableLeaseCost	31000	USD
	us-gaap	Variable Lease Cost VariableLeaseCost	92000	USD
CY2018Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	24768581	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	23417417	shares
CY2019Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	27470558	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	27403683	shares
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:13px;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-style:italic;font-weight:bold;">Risk and Uncertainties</font></div><div style="line-height:120%;padding-bottom:12px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">In 2013, Evolus and Daewoong Pharmaceuticals Co., Ltd. (“Daewoong”) entered into an agreement (the “Daewoong Agreement”), pursuant to which, the Company has an exclusive distribution license to Jeuveau</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">®</sup></font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"> from Daewoong for aesthetic indications in the United States, European Union, Canada, Australia, Russia, Commonwealth of Independent States, and South Africa, as well as co-exclusive distribution rights with Daewoong in Japan. Jeuveau</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">®</sup></font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"> is manufactured by Daewoong in a facility in South Korea. The Company also has the option to negotiate first with Daewoong to secure a distribution license for any product that Daewoong directly or indirectly develops or commercializes that is classified as an injectable botulinum toxin (other than Jeuveau®) in a territory covered by the Daewoong Agreement. The Company relies on Daewoong, its exclusive and sole supplier, to manufacture Jeuveau</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">®</sup></font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">. Any termination or loss of significant rights, including exclusivity, under the Daewoong Agreement would materially and adversely affect the Company’s commercialization of Jeuveau</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">®</sup></font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">. The Daewoong Agreement, and Daewoong’s rights relating to Jeuveau</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">®</sup></font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">, are subject to litigation. See </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">Note 8</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">. </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:italic;">Commitments and Contingencies</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"> for additional information regarding such litigation.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">The Company commercially launched Jeuveau</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">®</sup></font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"> in the United States in May 2019 and, as such, has a limited history of sales. Jeuveau</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">®</sup></font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"> also requires regulatory approval from certain regulatory authorities prior to commercial sales in the related jurisdictions. If any previously granted approval is retracted or the Company is denied approval or approval is delayed by any other regulators, it may have a material adverse impact on the Company’s business and its financial statements.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">The Company is subject to risks common to early stage companies in the pharmaceutical industry including, but not limited to, dependency on the clinical and commercial success of Jeuveau</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">®</sup></font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"> and any future product candidates, ability to obtain and maintain regulatory approval of Jeuveau</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">®</sup></font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"> and any future product candidates in the jurisdictions where approval is sought, the need for additional financing to achieve its goals, uncertainty of broad adoption of its approved products, if any, by physicians and patients, significant competition and untested manufacturing capabilities.</font></div><div style="line-height:120%;padding-bottom:13px;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-style:italic;font-weight:bold;"></font></div></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:13px;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:12px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">The preparation of financial statements in conformity with GAAP requires management to make estimates, judgments, and assumptions that affect the amounts reported in the financial statements and disclosures made in the accompanying notes. Actual results could materially differ from those estimates, judgments, and assumptions. Management considers many factors in selecting appropriate financial accounting policies and controls and in developing the estimates and assumptions that are used in the preparation of these financial statements. Management must apply significant judgment in this process. In addition, other factors may affect estimates, including expected business and operational changes, sensitivity and volatility associated with the assumptions used in developing estimates, and whether historical trends are expected to be representative of future trends. The estimation process often may yield a range of potentially reasonable estimates of the ultimate future outcomes, and management must select an amount that falls within that range of reasonable estimates.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">On an ongoing basis, the Company evaluates the most significant estimates, including those related to net revenues, allowance for doubtful accounts, fair value measurements, goodwill and long-lived asset valuations and impairment assessments, inventory valuations, income tax valuations and stock-based compensation expense, among others. Although the Company bases estimates on historical experience, knowledge of current events and actions it may undertake in the future, and on various other assumptions that are believed to be reasonable, this process may result in actual results differing materially from those estimated amounts used in the preparation of the financial statements.</font></div></div>

Files In Submission

Name	View Source	Status
0001570562-19-000143-index-headers.html	Edgar Link	pending
0001570562-19-000143-index.html	Edgar Link	pending
0001570562-19-000143.txt	Edgar Link	pending
0001570562-19-000143-xbrl.zip	Edgar Link	pending
eols-20190930.xml	Edgar Link	completed
eols-20190930.xsd	Edgar Link	pending
eols-20190930_cal.xml	Edgar Link	unprocessable
eols-20190930_def.xml	Edgar Link	unprocessable
eols-20190930_lab.xml	Edgar Link	unprocessable
eols-20190930_pre.xml	Edgar Link	unprocessable
evolus09301910-q.htm	Edgar Link	pending
exhibit31109301910q.htm	Edgar Link	pending
exhibit31209301910q.htm	Edgar Link	pending
exhibit321093019.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EOLS
Evolus, Inc. Stock $eols

2019 Q4 Form 10-Q Financial Statement

#000157056219000143 Filed on November 04, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EOLS Evolus, Inc. Stock $eols

2019 Q4 Form 10-Q Financial Statement

#000157056219000143 Filed on November 04, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EOLS
Evolus, Inc. Stock $eols